Expression of cytokine genes or proteins and signaling molecules in lymphocytes associated with human ovarian carcinoma

International Journal of Cancer

Volumn 68, Issue 3, 1996, Pages 276-284

  Rabinowich, Hannah ^a,b   Suminami, Yoshinori ^b   Reichert, Torsten E ^a,b   Crowley Nowick, Peggy ^a,b   Bell, Maria ^c   Edwards, Robert ^a,b   Whiteside, Theresa L ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; BIOPSY; CYTOKINES; FEMALE; GENE EXPRESSION; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; OVARIAN NEOPLASMS; PROTEIN SORTING SIGNALS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0029845820     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961104)68:3<276::AID-IJC2>3.0.CO;2-Z     Document Type: Article

References (27)

1. ALEXANDER, J.P., KUDOH, S., MELSOP, K.A., HAMILTON, T.A., EDINGER, M.G., TUBBS, R.R., SICA, D., TUASON, L., KLEIN, E., BUKOWSKI, R.M. and FINKE, J.H., T-cells infiltrating renal cell CA display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res., 53, 1380-1387 (1993).
2. CHEN, K., DEMETRIS, A.J., VAN THIEL, D.H. and WHITESIDE, T.L., Double immunoenzyme staining method for analysis of tissue and blood lymphocyte subsets with monoclonal antibodies. Lab. Invest., 56, 114-119 (1987).
3. FARACE, F., ANGEVIN, E., VANDERPLANCKE, J., ESCUDIER, B. and TRIEBEL, F., The decreased expression of CD3 ζ chains in cancer patients is not reversed by IL-2 administration. Int. J. Cancer, 59, 752-755 (1994).
4. lck in T-cells infiltrating human renal cell CA. Cancer Res., 53, 5613-5616 (1993).
5. FRANCO, J.L., GHOSH, P., WILTROUT, R.H., CARTER, C.R.D., ZEA, A.H., MOMOZAKI, N., OCHOA, A.C., LONGO, D.L., SAYERS, T.J. and KOMSCHLIES, K.L., Partial degradation of T-cell signal transduction molecules by contaminating granulocytes during protein extraction of splenic T cells from tumor-bearing mice. Cancer Res., 55, 3840-3846 (1995).
6. GHOSH, P., KOMSCHLIES, K.L., CIPPITELLI, M., LONGO, D.L., SUBLESKI, J., YE, J., SICA, A., YOUNG, H.A., WILTROUT. R.H. and OCHOA, A.C., Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth. J nat. Cancer Inst., 87, 1478-1483 (1995).
7. IOANNIDES, C.G. and WHITESIDE, T.L., T cell recognition of human tumors: implications for molecular immuno-therapy of cancer. Clin. Immunol. Immunopathol., 66, 91-106 (1993).
8. LAI, P., RABINOWICH, H., CROWLEY-NOWICK, P.A., BELL, M.C., MANTOVANI, G. and WHITESIDE, T.L., Alterations in expression and function of signal transduction proteins in tumor associated NK and T lymphocytes from patients with ovarian CA. Clin. Cancer Res., 2, 161-173 (1996).
9. LI, X., LIU, J., PARK, J.-K., HAMILTON, T.A., RAYMAN, P., KLEIN, E., EDINGER, M., TUBBS, R., BUKOWSKI, R. and FINKE, J., T cells from renal cell carcinoma patients exhibit an abnormal pattern of κB-specific DNA binding activity: a preliminary report. Cancer Res., 54, 5424-5429 (1994).
10. LIN, W.-C., YASUMURA, S., SUMINAMI, Y., SUNG, M.-W., NAGASHIMA, S., STANSON, J. and WHITESIDE, T.L., Constitutive production of interleukin 2 by human CA cells, expression of IL-2R and tumor cell growth. J. Immunol., 155, 4805-4816 (1995).
11. LUSCHER, U., FILGUEIRA, L., JURETIC, A., ZUBER, M., JUSCHER, N.J., HEBERER, M. and SPAGNOLI, G.C., The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes. Int. J. Cancer, 57, 612-619 (1994).
12. MAEURER, M.J., MARTIN, D.M., CASTELLI, C., ELDER, E., LEDER, G., STORKUS, W.J. and LOTZE, M.T., Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes. Cancer Immunol. Immunother., 41, 111-121 (1995).
13. MATSUDA, M., PETERSSON, M., LENKEI, R., TAUPIN, J.-L., MAGNUSSON, I., MELLSTEDT, H., ANDERSON, P. and KIESSLING, R., Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int. J. Cancer, 61, 765-772 (1995).
14. MERLO, A., JURETIC, A., ZUBER, M., FILGUEIRA, L., LUSCHER, U., CAETANO, V., ULRICH, J., GRATZL, O., HEBERER, M. and SPAGNOLI, G.C., Cytokine gene expression in primary brain tumors, metastases and meningiomas suggests specific transcription patterns. Europ. J. Cancer, 29A, 2118-2125 (1993).
15. MIESCHER, S., STOECK, M., QIAO, L., BARRAS, C., BARRELET, L. and VON FLIEDNER, V., Proliferative and cytolytic potentials of purified human tumor infiltrating T lymphocytes. Impaired response to mitogen-driven stimulation despite T cell receptor expression. Int. J. Cancer, 42, 659-666 (1988).
16. NAKAGOMI, H., PETERSSON, M., MAGNUSSON, I., JUHLIN, C., MATSUDA, M., MELLSTEDT, H., TAUPIN, J.-L., VIVIER, E., ANDERSON, P. and KIESSLING, R., Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T-cells and NK cells of patients with colorectal CA. Cancer Res., 53, 5610-5612 (1993).
17. PISA, P., HALAPI, E., PISA, E.K., GERDIN, E., HISING, C., BUCHT, A., GERDIN, B. and KIESSLING, R., Selective expression of interleukin 10, Interferon γ, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc. nat. Acad. Sci. (Wash.), 89, 7708-7712 (1992).
18. ROMAGNANI, S., Biology of human Th1 and Th2 cells. J. clin. Immunol., 15, 121-129 (1995).
19. ROSENBERG, S.A., YANNELLI, J.R., YANG, J.C., TOPALIAN, S.L., SCHWARTZENTRUBER, J., WEBER, J.S., PARKINSON, D.R., SEIPP, C.A., EINHORN, J.H. and WHITE, D.E., Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 1. J. nat. Cancer Inst., 86, 1195-1166 (1994).
20. + T cells secreting Th1 or Th2 cytokines. Immunity, 2, 271-279 (1995).
21. SICA, A., TAN, T.H., RICE, N., KRETZSCHMAR, M., GHOSH, P. and YOUNG, H.A., The c-rel protooncogene product c-Rel but not NF-kappa B binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulatable response element. Proc. nat. Acad. Sci. (Wash.), 89, 1740-1744 (1992).
22. VITOLO, D., ZERBE, T., KANBOUR, A., DAHL, C., HERBERMAN, R.B. and WHITESIDE, T.L., Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adeno CA and invasive breast cancer. Int. J. Cancer, 51, 573-580 (1992).
23. WANG, Q., REDOVAN, C., TUBBS, R., OLENCKI, T., KLEIN, E., KUDOH, S., FINKE, J. and BUKOWSKI, R.M., Selective cytokine gene expression in renal cell CA tumor cells and tumor-infiltrating lymphocytes. Int. J. Cancer, 61, 780-785 (1995).
24. WHITESIDE, T.L., Tumor-infiltrating lymphocytes in human malignancies, Medical Intelligence Unit, R.G. Landes, Austin, TX (1993).
25. WHITESIDE, T.L., Cytokines and cytokine measurements in a clinical laboratory. Clin. Diag. Lab. Immunol., 1, 257-260 (1994).
26. WHITESIDE, T.L., and PARMIANI, G., Tumor-infiltrating lymphocytes: their phenotype, function and clinical use. Cancer Immunol. Immunother, 39, 15-21 (1994).
27. YAMAMURA, M., MODLIN, R.L., OHMEN, J.D. and MOY, R.L., Local expression of antiinflammatory cytokines in cancer. J. clin. Invest., 91, 1005-1010 (1993).